Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Duffner, P. K.
Right arrow Articles by Shucard, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Duffner, P. K.
Right arrow Articles by Shucard, D. W.
NEUROLOGY 1989;39:373
© 1989 American Academy of Neurology

The significance of MRI abnormalities in children with neurofibromatosis

Patricia K. Duffner, MD, Michael E. Cohen, MD, F. Glen Seidel, MD and David W. Shucard, PhD

Departments of Neurology and Pediatrics, State University of New York at Buffalo, School of Medicine, Buffalo, NY. (Drs. Duffner, Cohen, and Shucard)
Department of Radiology, State University of New York at Buffalo, School of Medicine, Buffalo, NY. (Dr. Seidel)

We prospectively evaluated 47 children with neurofibromatosis to determine whether the previously reported high signals on magnetic resonance imaging (MRI) (prolonged T2) correlated with CT, brainstem auditory evoked responses (BAER), EEG, clinical examinations, cognitive abilities, or seizure disorder. Thirty percent of children had a history of seizures and 70% had either learning disabilities or mental retardation. Overall, 74% had an abnormal MRI examination. Sixty-two percent had high signals (prolonged T2) on T2-weighted images. Abnormal signals were located primarily in the basal ganglia, brainstem, and cerebellum. Twenty-five percent of patients had abnormal EEGs, 28% had abnormal CTs, and 27% had abnormal BAER examinations. The abnormal signals on MRI did not consistently relate to findings on CT, BAER, EEG, school placement, or clinical examination. The abnormal signals presumably reflect areas of abnormal brain parenchyma, either hamartomas, heterotopias, or local areas of brain dysplasia.

Address correspondence and reprint requests to Dr. Duffner, Department of Neurology and Pediatrics, State University of New York at Buffalo, School of Medicine, 219 Bryant Street, Buffalo, NY 14222.

Received May 31, 1988. Accepted for publication in final form September 26, 1988.




This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S. L Hyman, D. S Gill, E. A. Shores, A. Steinberg, and K. N North
T2 hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning
J. Neurol. Neurosurg. Psychiatry, October 1, 2007; 78(10): 1088 - 1091.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
L. Margari, A. Presicci, P. Ventura, S. M. Bacca, G. Iliceto, N. Medicamento, M. Buttiglione, and T. Perniola
Clinical and Instrumental (Magnetic Resonance Imaging [MRI] and Multimodal Evoked Potentials) Follow-Up of Brain Lesions in Three Young Patients With Neurofibromatosis 1
J Child Neurol, December 1, 2006; 21(12): 1085 - 1090.
[Abstract] [PDF]


Home page
NeurologyHome page
R. Feldmann, J. Denecke, M. Grenzebach, G. Schuierer, and J. Weglage
Neurofibromatosis type 1: Motor and cognitive function and T2-weighted MRI hyperintensities
Neurology, December 23, 2003; 61(12): 1725 - 1728.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
R. L. Billingsley, E. F. Jackson, J. M. Slopis, P. R. Swank, S. Mahankali, and B. D. Moore
Functional Magnetic Resonance Imaging of Phonologic Processing in Neurofibromatosis 1
J Child Neurol, November 1, 2003; 18(11): 731 - 740.
[Abstract] [PDF]


Home page
J Child NeurolHome page
A. G. Lasker, M. B. Denckla, and D. S. Zee
Ocular Motor Behavior of Children With Neurofibromatosis 1
J Child Neurol, May 1, 2003; 18(5): 348 - 355.
[Abstract] [PDF]


Home page
J Child NeurolHome page
K. North, S. Hyman, and B. Barton
Review Article : Cognitive Deficits in Neurofibromatosis 1
J Child Neurol, August 1, 2002; 17(8): 605 - 612.
[Abstract] [PDF]


Home page
J Child NeurolHome page
R. M. Costa and A. J. Silva
Review Article : Molecular and Cellular Mechanisms Underlying the Cognitive Deficits Associated With Neurofibromatosis 1
J Child Neurol, August 1, 2002; 17(8): 622 - 626.
[Abstract] [PDF]


Home page
Arch NeurolHome page
R. L. Billingsley, G. W. Schrimsher, E. F. Jackson, J. M. Slopis, and B. D. Moore III
Significance of Planum Temporale and Planum Parietale Morphologic Features in Neurofibromatosis Type 1
Arch Neurol, April 1, 2002; 59(4): 616 - 622.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
M. Di Capua, M. L. Lispi, A. Giannotti, D. Longo, and G. Fariello
Neurofibromatosis Type 1 Presenting With Hand Dystonia
J Child Neurol, August 1, 2001; 16(8): 606 - 608.
[Abstract] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
N TUBRIDY, F SCHON, A MOSS, A CLARKE, T COX, and R FERNER
Hippocampal involvement in identical twins with neurofibromatosis type 1
J. Neurol. Neurosurg. Psychiatry, July 1, 2001; 71(1): 131 - 132.
[Full Text]


Home page
Am. J. Neuroradiol.Home page
R. G. Steen, J. S. Taylor, J. W. Langston, J. O. Glass, V. R. Brewer, W. E. Reddick, R. Mages, and E. K. Pivnick
Prospective Evaluation of the Brain in Asymptomatic Children with Neurofibromatosis Type 1: Relationship of Macrocephaly to T1 Relaxation Changes and Structural Brain Abnormalities
AJNR Am. J. Neuroradiol., May 1, 2001; 22(5): 810 - 817.
[Abstract] [Full Text]


Home page
Arch OphthalmolHome page
C. F. Parsa, C. S. Hoyt, R. L. Lesser, J. M. Weinstein, C. M. Strother, R. Muci-Mendoza, M. Ramella, R. S. Manor, W. A. Fletcher, M. X. Repka, et al.
Spontaneous Regression of Optic Gliomas: Thirteen Cases Documented by Serial Neuroimaging
Arch Ophthalmol, April 1, 2001; 119(4): 516 - 529.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
E. C. Dubovsky, T. N. Booth, G. Vezina, C. A. Samango-Sprouse, K. M. Palmer, and C. O. Brasseux
MR Imaging of the Corpus Callosum in Pediatric Patients with Neurofibromatosis Type 1
AJNR Am. J. Neuroradiol., January 1, 2001; 22(1): 190 - 195.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
F. J. DiMario JR and S. Langshur
Headaches in Patients With Neurofibromatosis-1
J Child Neurol, April 1, 2000; 15(4): 235 - 238.
[Abstract] [PDF]


Home page
NeurologyHome page
B. D. Moore III, J. M. Slopis, E. F. Jackson, A. E. De Winter, and N. E. Leeds
Brain volume in children with neurofibromatosis type 1: Relation to neuropsychological status
Neurology, February 22, 2000; 54(4): 914 - 920.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
A. E. Kayl, B. D. Moore, J. M. Slopis, E. F. Jackson, and N. E. Leeds
Quantitative Morphology of the Corpus Callosum in Children With Neurofibromatosis and Attention-Deficit Hyperactivity Disorder
J Child Neurol, February 1, 2000; 15(2): 90 - 96.
[Abstract] [PDF]


Home page
Arch NeurolHome page
F. J. DiMario Jr, G. R. Ramsby, and J. A. Burleson
Brain Morphometric Analysis in Neurofibromatosis 1
Arch Neurol, November 1, 1999; 56(11): 1343 - 1346.
[Abstract] [Full Text] [PDF]


Home page
Neuro Oncol DukeHome page
A. E. De Winter, B. D. Moore III, J. M. Slopis, J. L. Ater, and D. R. Copeland
Brain tumors in children with neurofibromatosis: Additional neuropsychological morbidity?
Neuro-oncol, October 1, 1999; 1(4): 275 - 281.
[Abstract] [PDF]


Home page
PediatricsHome page
P. D. Griffiths, F. PhD, S. Blaser, W. Mukonoweshuro, D. Armstrong, G. Milo-Manson, and S. Cheung
Neurofibromatosis Bright Objects in Children With Neurofibromatosis Type 1: A Proliferative Potential?
Pediatrics, October 1, 1999; 104(4): 49e - 49.
[Abstract] [Full Text]


Home page
Arch NeurolHome page
F. J. DiMario Jr and G. Ramsby
Magnetic Resonance Imaging Lesion Analysis in Neurofibromatosis Type 1
Arch Neurol, April 1, 1998; 55(4): 500 - 505.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
A. M. Kaplan, K. Chen, M. A. Lawson, D. L. Wodrich, C. T. Bonstelle, and E. M. Reiman
Positron Emission Tomography in Children With Neurofibromatosis-1
J Child Neurol, November 1, 1997; 12(8): 499 - 506.
[Abstract] [PDF]


Home page
JAMAHome page
D. H. Gutmann, A. Aylsworth, J. C. Carey, B. Korf, J. Marks, R. E. Pyeritz, A. Rubenstein, and D. Viskochil
The Diagnostic Evaluation and Multidisciplinary Management of Neurofibromatosis 1 and Neurofibromatosis 2
JAMA, July 2, 1997; 278(1): 51 - 57.
[Abstract] [PDF]


Home page
J Child NeurolHome page
B. D. Moore, J. L. Ater, M. N. Needle, J. Slopis, and D. R. Copeland
Neuropsychological Profile of Children With Neurofibromatosis, Brain Tamor, or Both
J Child Neurol, October 1, 1994; 9(4): 368 - 377.
[Abstract] [PDF]


Home page
J Child NeurolHome page
J. R. Buchhalter
Inherited Epilepsies of Childhood
J Child Neurol, October 1, 1994; 9(1_suppl): S12 - S19.
[Abstract] [PDF]


Home page
J Child NeurolHome page
K. North
Neurofibromatosis Type 1: Review of the First 200 Patients in an Australian Clinic
J Child Neurol, October 1, 1993; 8(4): 395 - 402.
[Abstract] [PDF]


Home page
Arch DermatolHome page
A. P. Truhan and P. A. Filipek
Magnetic Resonance Imaging: Its Role in the Neuroradiologic Evaluation of Neurofibromatosis, Tuberous Sclerosis, and Sturge-Weber Syndrome
Arch Dermatol, February 1, 1993; 129(2): 219 - 226.
[Abstract] [PDF]


Home page
J Child NeurolHome page
F. J. DiMario Jr, G. Ramsby, R. Greenstein, S. Langshur, and B. Dunham
Neurofibromatosis Type 1: Magnetic Resonance Imaging Findings
J Child Neurol, January 1, 1993; 8(1): 32 - 39.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by AAN Enterprises, Inc.